Achieving Olympicene Functionalization Three Ways.

Abstract read

In one paragraph

Article in The Journal of organic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kaitlin M HartungDepartment of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Dr. East, Los Angeles, California 90095, United States.ORCID 0000-0001-9879-6606

Ellen M SlettenDepartment of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Dr. East, Los Angeles, California 90095, United States.ORCID 0000-0002-0049-7278

Funding

Biocompatible fluorophores for shortwave infrared imagingR01EB027172 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Ellen May Sletten · 2019 to 2026

$2.9M

Chemistry Biology Interface Training ProgramT32GM136614 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Patrick G. Harran · 2020 to 2026

$2.8M

Bioorthogonal host-guest chemistry for tandem imaging and therapyDP2GM132680 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SLETTEN, ELLEN MAY · 2018 to 2018

$2.3M

NMR Console and Prodigy CryoProbeS10OD028644 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GARG, NEIL K · 2021 to 2021

$600k

NIBIB NIH HHS R01 EB027172NIGMS NIH HHS DP2 GM132680NIGMS NIH HHS T32 GM136614NIH HHS S10 OD028644

6 · The paper itself

Abstract

Polycyclic aromatic hydrocarbons (PAHs) and their derivatives are of interest in many fields, from materials science to supramolecular chemistry. 6

Identifiers

PMID39698889

DOI10.1021/acs.joc.4c02471

PMCPMC11731307

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.